Related Experiment Video
Updated: Nov 8, 2025

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
Published on: May 2, 2025
Hepatic Steatosis in Patients With Single Ventricle and a Fontan Circulation
David A Katz1,2, Daniel Peck1,2, Adam M Lubert1,2
1Department of Pediatrics University of Cincinnati College of Medicine Cincinnati OH.
Insights
Hepatic steatosis, or fatty liver, affects 10.5% of Fontan circulation patients. Risk factors like obesity and dyslipidemia are similar to the general population, not Fontan hemodynamics.
Area of Science:
- Cardiology
- Hepatology
- Radiology
Background:
- Nonalcoholic fatty liver disease is a primary cause of chronic liver disease.
- The relationship between hepatic steatosis and liver disease post-Fontan procedure is unclear.
- This study investigates hepatic steatosis in Fontan circulation patients.
Purpose of the Study:
- To determine the prevalence of hepatic steatosis in patients with Fontan circulation.
- To identify associations between hepatic steatosis and patient characteristics.
- To explore the link between hepatic steatosis and Fontan hemodynamics.
Main Methods:
- Retrospective single-center study of 95 Fontan circulation patients.
- Liver magnetic resonance imaging (MRI) used between 2012 and 2019.
- Proton density fat fraction imaging determined liver fat percentage; hepatic steatosis defined as ≥5% liver fat.
Main Results:
- Hepatic steatosis was present in 10.5% of the cohort.
- Steatosis associated with higher BMI, obesity, lower HDL cholesterol, and increased subcutaneous fat.
- No association found between hepatic steatosis and cardiovascular imaging or hemodynamic variables.
Conclusions:
- Obesity and dyslipidemia are key risk factors for hepatic steatosis in Fontan patients.
- These risk factors mirror those observed in the general population.
- Fontan circulation hemodynamics do not appear to be associated with hepatic steatosis.
Abstract:
Background Hepatic steatosis, caused by nonalcoholic fatty liver disease, is a leading cause of chronic liver disease. The interplay between hepatic steatosis and the development of liver disease following the Fontan procedure is not well understood. This study examined the prevalence and associations of hepatic steatosis in patients with a Fontan circulation. Methods and Results This was a single-center retrospective study of 95 patients with a Fontan circulation with liver magnetic resonance imaging performed between 2012 and 2019. The average age at magnetic resonance imaging was 21.5±8.5 years. The percent liver fat signal was determined using magnetic resonance chemical shift-encoded proton density fat fraction imaging. Hepatic steatosis was defined as liver fat ≥5% and was present in 10.5% of the cohort. The presence of hepatic steatosis was associated with higher body mass index (29±4 versus 24±6 kg/m2, P=0.006), a higher frequency of obesity (50% versus 12%, P=0.015), lower high-density lipoprotein cholesterol (35±9 versus 43±14 mg/dL, P=0.050), and greater subcutaneous fat thickness (2.6±0.7 versus 1.8±1.0 cm, P=0.043). There was no association between hepatic steatosis and cardiovascular imaging or hemodynamic variables from cardiac catheterization. Conclusions Risk factors for hepatic steatosis in patients with Fontan circulation include obesity and dyslipidemia, similar to what is seen in the general population. Fontan hemodynamics were not associated with hepatic steatosis.
Related Concept Videos
Mitral Stenosis I: Introduction
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...

